The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
The NHS is looking for volunteers as part of the three cancer projects that have been selected as part of the NHS DigiTrials initiative. Almost 150,000 volunteers will take part in these trials to help transform cancer treatment.
In a study, researchers from the University of Basel and the University Hospital Basel have uncovered a promising new approach to combat the Epstein-Barr virus (EBV), a common virus that affects 90% of the adult population.
In a significant advancement for breast cancer treatment, a new blood test has shown the ability to predict the recurrence of breast cancer up to three years before tumours become detectable through conventional scans.
The University of Michigan Health Rogel Cancer Center has revealed that changing the dosing schedule for common cancer therapy could greatly reduce greenhouse gas emissions without compromising the patient's outcomes.
63.8% of the UK population are currently overweight or obese. Obesity is a major cause of ill health. Being moderately obese takes around 3 years off your life, whereas severe obesity shortens it by at least 10 years.
Researchers from Oxford Population Health's Cancer Epidemiology Unit have identified specific proteins in the blood that may predict a person's risk of developing various cancers over seven years before diagnosis.
In a recent study, researchers at the University of California San Diego have developed an experimental treatment made from a plant virus that shows effectiveness in protecting against a broad range of metastatic cancers in mice.
Zisis Kozlakidis from the World Health Organization’s International Agency for Cancer and Jiaao Yu from the Shanghai Jiao Tong University discuss the burden of lung cancer in Southeast Asia and China and the priorities for therapies and interventions.
Lorna Rothery spoke to the Cancer Drug Development Forum’s Managing Director, Professor Jaap Verweij and Chairperson of the CDDF Board of Directors, Professor Ruth Plummer, about opportunities and challenges in oncology research and treatment.
A scarcity of suitable therapies and geographic disparities in access to care are impacting survival rates for children with cancer; Lorna Rothery spoke to the European branch of Childhood Cancer International, a pan-European organisation committed to improving outcomes for children and adolescents affected by cancer.
Researchers suggest that microwave ablation, a minimally invasive procedure, could offer comparable progression-free survival rates to surgery with fewer complications.
A minimally invasive treatment for prostate cancer, using a combination of MRI and transurethral ultrasound, has shown effectiveness in a recent study.
Dr Alice Di Pasquale, Scientific Research Officer at Breast Cancer UK, explains why more must be done to increase awareness of Endocrine Disrupting Chemicals and breast cancer risk.
